This forecast from consensus appears to be realistic because CLS continues its strategic shift to a more profitable and rapidly growing CCS [Connectivity and Cloud Solutions] segment. Strong ...

Galway-based Complete Laboratory Solutions (CLS) is investing €9 million in staff training as it expands into new sectors and eyes up the prospects for international expansion. The privately ...

Celestica (CLS) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.86 per share a year ago. These figures ...

Sponsored by the U.S. Department of State, CLS Spark is a competitive opportunity that provides intensive language instruction and cultural enrichment experiences to American students, building ...

In its fourth quarter 2024 investor letter, Renaissance International Small Cap Strategy emphasized stocks such as Celestica Inc. (NYSE:CLS). Celestica Inc. (NYSE:CLS) is a supply chain solutions ...

In this article, we are going to take a look at where Celestica Inc. (NYSE:CLS) stands against the other stocks. The stock market kicked off the trading week in a bloodbath, erasing last week’s ...

In this article, we are going to take a look at where Celestica Inc. (NYSE:CLS) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as ...

Google Web Performance Advocate clarifies Cumulative Layout Shift (CLS) measurement, aiding web developers in optimizing Core Web Vitals. Google's Web Performance Advocate, Barry Pollard ...

Clearside’s CLS-AX (axitinib injectable suspension) has aced a phase 2b trial, achieving its primary and secondary outcomes for patients with neovascular age-related macular degeneration (wet AMD).

CLS has been steadily expanding and refining its services to meet the diverse needs of the foreign exchange industry, with a strong emphasis on reducing settlement risks and boosting operational ...